Assembly Biosciences financial statements
어셈블리 바이오사이언시스NASDAQ:ASMB · Nasdaq · Healthcare$22.74+0.89%
2026-10-05 closeAssembly Biosciences's published financial data is dated 2026-10-04. 2024 revenue was $29M. 2024 operating profit was −$45M.
Reported results
Quantus Signal · live data · not investment advice · Privacy Policy